Cannabis Hyperemesis Syndrome in Children: A Review of Epidemiology, Pathology, Diagnosis, and Treatment
- PMID: 40304055
- DOI: 10.1097/PEC.0000000000003355
Cannabis Hyperemesis Syndrome in Children: A Review of Epidemiology, Pathology, Diagnosis, and Treatment
Abstract
Cannabis remains one of the most frequently misused substances among adolescents. As recreational cannabis has proliferated across the United States, cannabis-related emergency department visits have increased. Cannabis hyperemesis syndrome, a variant of cyclic vomiting syndrome, has emerged as a recognized but poorly understood complication of chronic cannabis use among a subset of individuals. Cannabis hyperemesis syndrome is characterized by repeated cycles of abdominal pain, nausea, and vomiting refractory to standard antiemetics, with users reporting the compulsive use of hot showers to mitigate symptoms. Treatment modalities include intravenous fluid and electrolyte repletion, topical application of capsaicin, and the use of antidopaminergics (eg, droperidol, haloperidol).
Keywords: cannabis hyperemesis syndrome; cyclic vomiting syndrome; marijuana.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Haloperidol for treatment of cannabinoid hyperemesis syndrome.Am J Emerg Med. 2013 Jun;31(6):1003.e5-6. doi: 10.1016/j.ajem.2013.02.021. Epub 2013 Apr 10. Am J Emerg Med. 2013. PMID: 23583118
-
Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment.J Emerg Nurs. 2021 May;47(3):483-486. doi: 10.1016/j.jen.2020.11.006. Epub 2021 Mar 10. J Emerg Nurs. 2021. PMID: 33712244 Review.
-
Cannabinoid hyperemesis syndrome.Curr Drug Abuse Rev. 2011 Dec;4(4):241-9. doi: 10.2174/1874473711104040241. Curr Drug Abuse Rev. 2011. PMID: 22150623 Free PMC article. Review.
-
Proper counseling for diagnosis and management of cannabinoid hyperemesis syndrome: a case report.Fam Pract. 2025 Feb 7;42(2):cmae067. doi: 10.1093/fampra/cmae067. Fam Pract. 2025. PMID: 39566098
-
[Cyclical hyperemesis secondary to cannabis abuse].Gastroenterol Hepatol. 2009 Jun-Jul;32(6):406-9. doi: 10.1016/j.gastrohep.2009.02.002. Epub 2009 May 27. Gastroenterol Hepatol. 2009. PMID: 19477551 Spanish.
References
-
- Miech RA, Johnston LD, Patrick ME, et al. Monitoring the Future National Survey Results on Drug Use, 1975–2023: Overview and Detailed Results for Secondary School Students Monitoring the Future Monograph Series. Ann Arbor, MI: Institute for Social Research, University of Michigan; 2024. Accessed May 17, 2024. http://monitoringthefuture.org/wp-content/uploads/2024/01/mtfoverview202...
-
- Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health (HHS Publication No. PEP23-07-01-006, NSDUH Series H-58). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2023 https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report
-
- State Medical Cannabis Laws. National Conference of State Legislatures. Accessed July 27, 2023. http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
-
- Coley RL, Carey N, Kruzik C, et al. Recreational cannabis legalization, retail sales, and adolescent substance use through 2021. JAMA Pediatr. 2024;178:622–625.
-
- Cohen N, Galvis Blanco L, Davis A, et al. Pediatric cannabis intoxication trends in the pre and post-legalization era. Clin Toxicol. 2022;60:53–58.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials